The research team of Frias et al designed a 32-week, randomized, double-blind, parallel-group, active control trial that included adults with a diagnosis of type 2 diabetes and a body mass index of 27 and HbA1C levels ranging from 7.5% to 10% despite a daily dose of metformin
The FDAs category-2 page says GHK-Cu has been withdrawn from category 2, and the agency plans to consult PCAC about it before the end of February 2027
Recalls & Warnings February 07, 2011 Maker of Hoodia and Green Tea Products to Pay $2.65 Million Settlement for Unfair Business Practices On February 1, 2011, supplement maker Irwin Naturals agreed to pay civil penalties, consumer restitution, and and investigative costs to settle a suit in California alleging that Irwin Naturals marketed Hoodia products that did not contain the hoodia gordonii herb despite the product labeling
This article is a starting point for education, not a guide to self-treatment